MetaADEDB 2.0 @ LMMD
sofosbuvir-velpatasvir drug combination
(HCOFYZXVHCYVAU-OTBOHSEESA-N)
Structure
SMILES
CC(OC(=O)[C@@H](N[P@](=O)(Oc1ccccc1)OC[C@H]1O[C@H]([C@]([C@@H]1O)(C)F)n1ccc(=O)[nH]c1=O)C)C.COC[C@H]1C[C@H](N(C1)C(=O)[C@@H](c1ccccc1)NC(=O)OC)c1ncc([nH]1)c1ccc2c(c1)COc1c2cc2ccc3c(c2c1)nc([nH]3)[C@@H]1CC[C@@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C
Molecular Formula:
C71H83FN11O17P
Molecular Weight:
1412.450
Log P:
10.4365
Hydrogen Bond Acceptor:
25
Hydrogen Bond Donor:
7
TPSA:
361.09
CAS Number(s):
N/A
Synonym(s)
1.
sofosbuvir-velpatasvir drug combination
2.
Epclusa
3.
sofosbuvir velpatasvir drug combination
4.
sofosbuvir, velpatasvir drug combination
External Link(s)
MeSHC000611331
PubChem Compound91885554
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 1373
Canada Vigilance: 4
Canada Vigilance
US FAERS
2HeadacheFAERS: 1123
Canada Vigilance: 2
Canada Vigilance
US FAERS
3NauseaFAERS: 550
Canada Vigilance: 3
Canada Vigilance
US FAERS
4Drug dose omissionFAERS: 181US FAERS
5DyspepsiaFAERS: 119US FAERS
6DizzinessFAERS: 110
Canada Vigilance: 1
Canada Vigilance
US FAERS
7VomitingFAERS: 100
Canada Vigilance: 3
Canada Vigilance
US FAERS
8Abdominal discomfortFAERS: 99US FAERS
9PruritusFAERS: 85US FAERS
10ArthralgiaFAERS: 78US FAERS
11ConstipationFAERS: 75US FAERS
12PainFAERS: 73US FAERS
13AlopeciaFAERS: 66US FAERS
14Drug ineffectiveFAERS: 59
Canada Vigilance: 8
Canada Vigilance
US FAERS
15Product dose omissionFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Dry skinFAERS: 56US FAERS
17AstheniaFAERS: 55US FAERS
18Memory impairmentFAERS: 53US FAERS
19AnxietyFAERS: 48US FAERS
20Abdominal PainFAERS: 46
Canada Vigilance: 2
Canada Vigilance
US FAERS
21Hepatitis CFAERS: 44
Canada Vigilance: 7
Canada Vigilance
US FAERS
22SomnolenceFAERS: 44US FAERS
23MyalgiaFAERS: 43US FAERS
24treatment failureFAERS: 41
Canada Vigilance: 14
Canada Vigilance
US FAERS
25Back PainFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Feeling abnormalFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Intentional dose omissionFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
28NasopharyngitisFAERS: 39US FAERS
29Maternal exposure during pregnancyFAERS: 32US FAERS
30Peripheral swellingFAERS: 32US FAERS
31Weight decreasedFAERS: 30US FAERS
32Wrong technique in product usage processFAERS: 29US FAERS
33Intentional product use issueFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
34Chest PainFAERS: 26US FAERS
35FlatulenceFAERS: 25US FAERS
36Therapy cessationFAERS: 25US FAERS
37Oropharyngeal painFAERS: 24US FAERS
38PneumoniaFAERS: 24
Canada Vigilance: 4
Canada Vigilance
US FAERS
39Product use issueFAERS: 23US FAERS
40TremorFAERS: 22US FAERS
41MalaiseFAERS: 20US FAERS
42ChillsFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
43DehydrationFAERS: 19US FAERS
44DysgeusiaFAERS: 18US FAERS
45Product use complaintFAERS: 17US FAERS
46Joint swellingFAERS: 15US FAERS
47Night sweatsFAERS: 15US FAERS
48PancreatitisFAERS: 15US FAERS
49ThirstFAERS: 15US FAERS
50AmnesiaFAERS: 14US FAERS
51HypersensitivityFAERS: 14US FAERS
52Bone painFAERS: 13US FAERS
53Extra dose administeredFAERS: 13US FAERS
54Initial insomniaFAERS: 13US FAERS
55Neck PainFAERS: 13US FAERS
56OverdoseFAERS: 13US FAERS
57TinnitusFAERS: 13US FAERS
58InfluenzaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Insurance issueFAERS: 12US FAERS
60Urinary tract infectionFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
61BronchitisFAERS: 11US FAERS
62ChromaturiaFAERS: 11US FAERS
63EpistaxisFAERS: 11US FAERS
64Genotype drug resistance test positiveFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
65Inappropriate schedule of drug administrationFAERS: 11US FAERS
66InfectionFAERS: 11US FAERS
67PalpitationsFAERS: 11US FAERS
68SinusitisFAERS: 11US FAERS
69AscitesFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
70HypersomniaFAERS: 10US FAERS
71PhotophobiaFAERS: 10US FAERS
72Pulmonary congestionFAERS: 10US FAERS
73Musculoskeletal PainFAERS: 9US FAERS
74StressFAERS: 9US FAERS
75UrticariaFAERS: 9US FAERS
76AcneFAERS: 8US FAERS
77AgitationFAERS: 8US FAERS
78Blood creatinine increasedFAERS: 8US FAERS
79Hepatitis C virus test positiveFAERS: 8US FAERS
80Mood swingsFAERS: 8US FAERS
81Rash erythematousFAERS: 8US FAERS
82SwellingFAERS: 8US FAERS
83Accidental overdoseFAERS: 7US FAERS
84Blood glucose increasedFAERS: 7US FAERS
85HungerFAERS: 7US FAERS
86Incorrect drug administration durationFAERS: 7US FAERS
87Product distribution issueFAERS: 7US FAERS
88ToothacheFAERS: 7US FAERS
89Blood glucose decreasedFAERS: 6US FAERS
90DisorientationFAERS: 6US FAERS
91ErythemaFAERS: 6US FAERS
92Facial paralysisFAERS: 6US FAERS
93Feeling ColdFAERS: 6US FAERS
94Impaired work abilityFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
95LethargyFAERS: 6US FAERS
96Loss of personal independence in daily activitiesFAERS: 6US FAERS
97Middle insomniaFAERS: 6US FAERS
98NervousnessFAERS: 6US FAERS
99Product storage errorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
100StomatitisFAERS: 6US FAERS
101SyncopeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Unevaluable eventFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Visual ImpairmentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
104AngioedemaFAERS: 5US FAERS
105BradycardiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
106Cardiac ArrestFAERS: 5US FAERS
107Cerebrovascular accidentFAERS: 5US FAERS
108Chest discomfortFAERS: 5US FAERS
109DiscomfortFAERS: 5US FAERS
110DysuriaFAERS: 5US FAERS
111Emotional disorderFAERS: 5US FAERS
112Exposure via body fluidFAERS: 5US FAERS
113GoutFAERS: 5US FAERS
114Incorrect dose administeredFAERS: 5US FAERS
115Multiple allergiesFAERS: 5US FAERS
116Myocardial InfarctionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
117Product packaging quantity issueFAERS: 5US FAERS
118Skin UlcerFAERS: 5US FAERS
119SluggishnessFAERS: 5US FAERS
120Therapy non-responderFAERS: 5US FAERS
121White blood cell count decreasedFAERS: 5US FAERS
122Acute kidney injuryFAERS: 4US FAERS
123Alanine Aminotransferase IncreasedFAERS: 4US FAERS
124ArthritisFAERS: 4US FAERS
125Aspartate Aminotransferase IncreasedFAERS: 4US FAERS
126Burning sensationFAERS: 4US FAERS
127CryingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
128CystitisFAERS: 4US FAERS
129Depressed moodFAERS: 4US FAERS
130Eye painFAERS: 4US FAERS
131FlushingFAERS: 4US FAERS
132HepatomegalyFAERS: 4US FAERS
133HypotensionFAERS: 4US FAERS
134Muscle strainFAERS: 4US FAERS
135Musculoskeletal chest painFAERS: 4US FAERS
136NephrolithiasisFAERS: 4US FAERS
137Oral painFAERS: 4US FAERS
138Poor quality sleepFAERS: 4US FAERS
139Product size issueFAERS: 4US FAERS
140Renal painFAERS: 4US FAERS
141RestlessnessFAERS: 4US FAERS
142SepsisFAERS: 4US FAERS
143ThrombosisFAERS: 4US FAERS
144Tooth ExtractionFAERS: 4US FAERS
145UlcerFAERS: 4US FAERS
146VertigoFAERS: 4US FAERS
147Viral load increasedFAERS: 4US FAERS
148WheezingFAERS: 4US FAERS
149AgeusiaFAERS: 3US FAERS
150AngerFAERS: 3US FAERS
151AphasiaFAERS: 3US FAERS
152Arthropod biteFAERS: 3US FAERS
153BlindnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
154Blood creatine phosphokinase increasedFAERS: 3US FAERS
155Blood potassium decreasedFAERS: 3US FAERS
156Blood potassium increasedFAERS: 3US FAERS
157Dental cariesFAERS: 3US FAERS
158Depressed Level of ConsciousnessFAERS: 3US FAERS
159Diabetes MellitusFAERS: 3US FAERS
160Drug dispensing errorFAERS: 3US FAERS
161EructationFAERS: 3US FAERS
162Feeling jitteryFAERS: 3US FAERS
163Flank PainFAERS: 3US FAERS
164FolliculitisFAERS: 3US FAERS
165Gait inabilityFAERS: 3US FAERS
166HerniaFAERS: 3US FAERS
167Inappropriate schedule of product administrationFAERS: 3US FAERS
168Increased tendency to bruiseFAERS: 3US FAERS
169Irritable Bowel SyndromeFAERS: 3US FAERS
170Joint stiffnessFAERS: 3US FAERS
171Lower respiratory tract infectionFAERS: 3US FAERS
172Musculoskeletal stiffnessFAERS: 3US FAERS
173Nephrotic SyndromeFAERS: 3US FAERS
174NeutropeniaFAERS: 3US FAERS
175PharyngitisFAERS: 3US FAERS
176Portal Vein ThrombosisFAERS: 3US FAERS
177Product dispensing errorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Product physical issueFAERS: 3US FAERS
179Product quality issueFAERS: 3US FAERS
180Productive CoughFAERS: 3US FAERS
181PsoriasisFAERS: 3US FAERS
182Respiratory tract congestionFAERS: 3US FAERS
183RetchingFAERS: 3US FAERS
184RhabdomyolysisFAERS: 3US FAERS
185Sinus headacheFAERS: 3US FAERS
186Skin irritationFAERS: 3US FAERS
187Therapeutic response unexpectedFAERS: 3US FAERS
188Throat irritationFAERS: 3US FAERS
189Viral upper respiratory tract infectionFAERS: 3US FAERS
190Wrong scheduleFAERS: 3US FAERS
191Abdominal rigidityFAERS: 2US FAERS
192AbscessFAERS: 2US FAERS
193Activities of daily living impairedFAERS: 2US FAERS
194Acute psychosisFAERS: 2US FAERS
195Ammonia increasedFAERS: 2US FAERS
196Animal biteFAERS: 2US FAERS
197ApathyFAERS: 2US FAERS
198Arrhythmogenic Right Ventricular DysplasiaFAERS: 2US FAERS
199ArthropathyFAERS: 2US FAERS
200AsthmaFAERS: 2US FAERS
201Atrial FibrillationFAERS: 2US FAERS
202Atrial FlutterFAERS: 2US FAERS
203Atrial tachycardiaFAERS: 2US FAERS
204Back disorderFAERS: 2US FAERS
205BlepharitisFAERS: 2US FAERS
206Blood cholesterol increasedFAERS: 2US FAERS
207Blood glucose abnormalFAERS: 2US FAERS
208Blood urea increasedFAERS: 2US FAERS
209Blood urine presentFAERS: 2US FAERS
210Bowel movement irregularityFAERS: 2US FAERS
211CellulitisFAERS: 2US FAERS
212CholangiocarcinomaFAERS: 2US FAERS
213CholelithiasisFAERS: 2US FAERS
214Chronic gastritisFAERS: 2US FAERS
215Clostridium difficile colitisFAERS: 2US FAERS
216Clostridium difficile infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
217Cold sweatFAERS: 2US FAERS
218ColitisFAERS: 2US FAERS
219ConjunctivitisFAERS: 2US FAERS
220Contraindicated product administeredFAERS: 2US FAERS
221DeformityFAERS: 2US FAERS
222Drug abuseFAERS: 2US FAERS
223Erectile dysfunctionFAERS: 2US FAERS
224Eye irritationFAERS: 2US FAERS
225Feeling of body temperature changeFAERS: 2US FAERS
226FibromyalgiaFAERS: 2US FAERS
227FormicationFAERS: 2US FAERS
228GastritisFAERS: 2US FAERS
229Gastrointestinal infectionFAERS: 2US FAERS
230Hepatic EncephalopathyFAERS: 2US FAERS
231Hepatitis BFAERS: 2US FAERS
232Hepatitis C RNA increasedFAERS: 2US FAERS
233Hernia painFAERS: 2US FAERS
234HordeolumFAERS: 2US FAERS
235Hypertensive crisisFAERS: 2US FAERS
236HyperthyroidismFAERS: 2US FAERS
237Inability to afford medicationFAERS: 2US FAERS
238LacerationFAERS: 2US FAERS
239LeukopeniaFAERS: 2US FAERS
240Lip swellingFAERS: 2US FAERS
241Lipase increasedFAERS: 2US FAERS
242Manufacturing product shipping issueFAERS: 2US FAERS
243Musculoskeletal discomfortFAERS: 2US FAERS
244NeuralgiaFAERS: 2US FAERS
245Nipple painFAERS: 2US FAERS
246ParanoiaFAERS: 2US FAERS
247Post procedural complicationFAERS: 2US FAERS
248PresyncopeFAERS: 2US FAERS
249Product availability issueFAERS: 2US FAERS
250Product communication issueFAERS: 2US FAERS
251Product difficult to swallowFAERS: 2US FAERS
252Product supply issueFAERS: 2US FAERS
253Respiratory FailureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
254SchizophreniaFAERS: 2US FAERS
255SciaticaFAERS: 2US FAERS
256ShockFAERS: 2US FAERS
257Skin reactionFAERS: 2US FAERS
258SneezingFAERS: 2US FAERS
259Suicide attemptFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
260Thermal burnFAERS: 2US FAERS
261ThrombocytopeniaFAERS: 2US FAERS
262Tongue blisteringFAERS: 2US FAERS
263Unresponsive to stimuliFAERS: 2US FAERS
264Upper-airway cough syndromeFAERS: 2US FAERS
265Urinary IncontinenceFAERS: 2US FAERS
266Ventricular FibrillationFAERS: 2US FAERS
267Ventricular FlutterFAERS: 2US FAERS
268Vitreous floatersFAERS: 2US FAERS
269colonoscopyFAERS: 2US FAERS
270furuncleFAERS: 2US FAERS
271Acute cardiac eventFAERS: 1US FAERS
272Acute myocardial infarctionFAERS: 1US FAERS
273AdenocarcinomaFAERS: 1US FAERS
274Adjustment disorder with depressed moodFAERS: 1US FAERS
275Adverse eventFAERS: 1US FAERS
276Agitated depressionFAERS: 1US FAERS
277Alcohol abuseFAERS: 1US FAERS
278Ammonia abnormalFAERS: 1US FAERS
279Amyotrophic Lateral SclerosisFAERS: 1US FAERS
280Anaphylactic shockFAERS: 1US FAERS
281Angina PectorisFAERS: 1US FAERS
282Anorectal swellingFAERS: 1US FAERS
283Aortic Valve StenosisFAERS: 1US FAERS
284AphoniaFAERS: 1US FAERS
285Apparent deathFAERS: 1US FAERS
286AsthenopiaFAERS: 1US FAERS
287Atypical pneumoniaFAERS: 1US FAERS
288Autoimmune hepatitisFAERS: 1US FAERS
289Autoimmune uveitisFAERS: 1US FAERS
290Basal cell carcinomaFAERS: 1US FAERS
291BedriddenFAERS: 1US FAERS
292Biliary ColicFAERS: 1US FAERS
293Blood albumin decreasedFAERS: 1US FAERS
294Blood bilirubin unconjugated increasedFAERS: 1US FAERS
295Blood creatine abnormalFAERS: 1US FAERS
296Blood iron decreasedFAERS: 1US FAERS
297Blood iron increasedFAERS: 1US FAERS
298Blood pressure fluctuationFAERS: 1US FAERS
299Blood triglycerides increasedFAERS: 1US FAERS
300Breast tendernessFAERS: 1US FAERS
301BronchiectasisFAERS: 1US FAERS
302BruxismFAERS: 1US FAERS
303BursitisFAERS: 1US FAERS
304Carbon Monoxide PoisoningFAERS: 1US FAERS
305Cardiac FlutterFAERS: 1US FAERS
306Cardiac discomfortFAERS: 1US FAERS
307CataractFAERS: 1US FAERS
308Cervix carcinomaFAERS: 1US FAERS
309ChokingFAERS: 1US FAERS
310CholestasisFAERS: 1US FAERS
311ChoreoathetosisFAERS: 1US FAERS
312Chronic Fatigue SyndromeFAERS: 1US FAERS
313Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
314ClumsinessFAERS: 1US FAERS
315Colonoscopy abnormalFAERS: 1US FAERS
316Contraindicated product prescribedFAERS: 1US FAERS
317Creatinine renal clearance decreasedFAERS: 1US FAERS
318DeafnessFAERS: 1US FAERS
319Death of relativeFAERS: 1US FAERS
320DementiaFAERS: 1US FAERS
321Diastolic hypertensionFAERS: 1US FAERS
322Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
323DiplopiaFAERS: 1US FAERS
324Disease complicationFAERS: 1US FAERS
325DiverticulitisFAERS: 1US FAERS
326Drug effect incompleteFAERS: 1US FAERS
327Drug screen positiveFAERS: 1US FAERS
328Duodenal UlcerFAERS: 1US FAERS
329DyscheziaFAERS: 1US FAERS
330DysphoniaFAERS: 1US FAERS
331Economic problemFAERS: 1US FAERS
332Ectopic PregnancyFAERS: 1US FAERS
333EczemaFAERS: 1US FAERS
334Electrolyte imbalanceFAERS: 1US FAERS
335EncephalitisFAERS: 1US FAERS
336EnuresisFAERS: 1US FAERS
337EpilepsyFAERS: 1US FAERS
338Escherichia infectionFAERS: 1US FAERS
339ExcoriationFAERS: 1US FAERS
340Exposure to toxic agentFAERS: 1US FAERS
341Exposure via breast milkFAERS: 1US FAERS
342Eyelid margin crustingFAERS: 1US FAERS
343Facial ParesisFAERS: 1US FAERS
344Foreign body in respiratory tractFAERS: 1US FAERS
345Full blood count decreasedFAERS: 1US FAERS
346GastrectomyFAERS: 1US FAERS
347Gastric BypassFAERS: 1US FAERS
348Gastric infectionFAERS: 1US FAERS
349Gastric pH decreasedFAERS: 1US FAERS
350Gastrointestinal PainFAERS: 1US FAERS
351Gastrointestinal motility disorderFAERS: 1US FAERS
352Gastrointestinal ulcerFAERS: 1US FAERS
353GastrostomyFAERS: 1US FAERS
354Gene MutationFAERS: 1US FAERS
355Gene mutation identification test positiveFAERS: 1US FAERS
356GingivitisFAERS: 1US FAERS
357GlaucomaFAERS: 1US FAERS
358Hallucinations, mixedFAERS: 1US FAERS
359Head discomfortFAERS: 1US FAERS
360Head titubationFAERS: 1US FAERS
361Heat ExhaustionFAERS: 1US FAERS
362Heat illnessFAERS: 1US FAERS
363HemiparesisFAERS: 1US FAERS
364Hepatitis AFAERS: 1US FAERS
365HepatitisFAERS: 1US FAERS
366Hepatorenal SyndromeFAERS: 1US FAERS
367Hip surgeryFAERS: 1US FAERS
368Hyperosmolar stateFAERS: 1US FAERS
369HypokinesiaFAERS: 1US FAERS
370HypophagiaFAERS: 1US FAERS
371Hypopharyngeal CancerFAERS: 1US FAERS
372HypothyroidismFAERS: 1US FAERS
373HypotrichosisFAERS: 1US FAERS
374IleusFAERS: 1US FAERS
375Illness anxiety disorderFAERS: 1US FAERS
376Immune Reconstitution Inflammatory SyndromeFAERS: 1US FAERS
377Incorrect product administration durationFAERS: 1US FAERS
378InflammationFAERS: 1US FAERS
379Intentional product misuseFAERS: 1US FAERS
380Intra-abdominal fluid collectionFAERS: 1US FAERS
381Joint injuryFAERS: 1US FAERS
382KetoacidosisFAERS: 1US FAERS
383LaryngitisFAERS: 1US FAERS
384LazinessFAERS: 1US FAERS
385LeukoencephalopathyFAERS: 1US FAERS
386Limb discomfortFAERS: 1US FAERS
387Limb injuryFAERS: 1US FAERS
388Lip erythemaFAERS: 1US FAERS
389Lip exfoliationFAERS: 1US FAERS
390Liver carcinoma rupturedFAERS: 1US FAERS
391Lower respiratory tract congestionFAERS: 1US FAERS
392LymphadenopathyFAERS: 1US FAERS
393LymphangitisFAERS: 1US FAERS
394LymphocytosisFAERS: 1US FAERS
395Maternal exposure before pregnancyFAERS: 1US FAERS
396Maternal exposure timing unspecifiedFAERS: 1US FAERS
397Maxillofacial operationFAERS: 1US FAERS
398Mechanical ventilationFAERS: 1US FAERS
399Medication ErrorFAERS: 1US FAERS
400Meningeal repairFAERS: 1US FAERS
401MenopauseFAERS: 1US FAERS
402Mental impairmentFAERS: 1US FAERS
403Mental status changesFAERS: 1US FAERS
404Mouth swellingFAERS: 1US FAERS
405Muscle FatigueFAERS: 1US FAERS
406Muscle tightnessFAERS: 1US FAERS
407Muscular DystrophyFAERS: 1US FAERS
408Myasthenia GravisFAERS: 1US FAERS
409MydriasisFAERS: 1US FAERS
410MyocarditisFAERS: 1US FAERS
411MyositisFAERS: 1US FAERS
412Nail cuticle fissureFAERS: 1US FAERS
413Nail pigmentationFAERS: 1US FAERS
414Nerve injuryFAERS: 1US FAERS
415NeurodermatitisFAERS: 1US FAERS
416No adverse eventFAERS: 1US FAERS
417NoduleFAERS: 1US FAERS
418Ocular discomfortFAERS: 1US FAERS
419Ocular icterusFAERS: 1US FAERS
420OnychalgiaFAERS: 1US FAERS
421OnychoclasisFAERS: 1US FAERS
422OphthalmoplegiaFAERS: 1US FAERS
423OrchitisFAERS: 1US FAERS
424Osteogenesis ImperfectaFAERS: 1US FAERS
425Pain of skinFAERS: 1US FAERS
426PallorFAERS: 1US FAERS
427PancreaticoduodenectomyFAERS: 1US FAERS
428PancytopeniaFAERS: 1US FAERS
429Paternal exposure during pregnancyFAERS: 1US FAERS
430Penile blisterFAERS: 1US FAERS
431PericarditisFAERS: 1US FAERS
432Peripheral arthritisFAERS: 1US FAERS
433PeritonitisFAERS: 1US FAERS
434Physical assaultFAERS: 1US FAERS
435PneumonitisFAERS: 1US FAERS
436Portal HypertensionFAERS: 1US FAERS
437Post procedural infectionFAERS: 1US FAERS
438PregnancyFAERS: 1US FAERS
439Product complaintFAERS: 1US FAERS
440Product container issueFAERS: 1US FAERS
441Product packaging issueFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
442Product taste abnormalFAERS: 1US FAERS
443Protein urine presentFAERS: 1US FAERS
444Psychiatric symptomFAERS: 1US FAERS
445Pulmonary EmbolismFAERS: 1US FAERS
446Pulmonary HypertensionFAERS: 1US FAERS
447Pulmonary painFAERS: 1US FAERS
448Pulmonary thrombosisFAERS: 1US FAERS
449Quality of life decreasedFAERS: 1US FAERS
450Respiratory DepressionFAERS: 1US FAERS
451Restless Legs SyndromeFAERS: 1US FAERS
452SarcoidosisFAERS: 1US FAERS
453ScabFAERS: 1US FAERS
454Secretion dischargeFAERS: 1US FAERS
455Septic ShockFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Serotonin SyndromeFAERS: 1US FAERS
457Sexual DysfunctionFAERS: 1US FAERS
458Skin lacerationFAERS: 1US FAERS
459Skin tightnessFAERS: 1US FAERS
460SomnambulismFAERS: 1US FAERS
461Spinal column stenosisFAERS: 1US FAERS
462Sudden deathFAERS: 1US FAERS
463SunburnFAERS: 1US FAERS
464Symptom recurrenceFAERS: 1US FAERS
465TattooFAERS: 1US FAERS
466Temperature intoleranceFAERS: 1US FAERS
467Tension HeadacheFAERS: 1US FAERS
468TensionFAERS: 1US FAERS
469Thyroid hormones increasedFAERS: 1US FAERS
470Tinea PedisFAERS: 1US FAERS
471Tongue discomfortFAERS: 1US FAERS
472TonsillitisFAERS: 1US FAERS
473Tooth InfectionFAERS: 1US FAERS
474Tooth LossFAERS: 1US FAERS
475Toxicity to various agentsFAERS: 1US FAERS
476Transaminases increasedFAERS: 1US FAERS
477UnderweightFAERS: 1US FAERS
478Urinary RetentionFAERS: 1US FAERS
479Urine flow decreasedFAERS: 1US FAERS
480Urine output increasedFAERS: 1US FAERS
481Vaginal DischargeFAERS: 1US FAERS
482Vascular ruptureFAERS: 1US FAERS
483VasculitisFAERS: 1US FAERS
484Viral load decreasedFAERS: 1US FAERS
485VitiligoFAERS: 1US FAERS
486Vulvovaginal discomfortFAERS: 1US FAERS
487Vulvovaginal drynessFAERS: 1US FAERS
488Vulvovaginal mycotic infectionFAERS: 1US FAERS
489Waist circumference increasedFAERS: 1US FAERS
490Walking aid userFAERS: 1US FAERS
491Walking distance test abnormalFAERS: 1US FAERS
492Wound InfectionFAERS: 1US FAERS
493Wrong drug administeredFAERS: 1US FAERS
494Wrong patient received medicationFAERS: 1US FAERS
495X-ray dental abnormalFAERS: 1US FAERS
496gallbladder neoplasmFAERS: 1US FAERS
497intensive careFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
498jaundiceFAERS: 1US FAERS
499nervous system disorderFAERS: 1US FAERS
500Wrong doseCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.